Venture Point Business Park
58 Evans Road
+44 151 728 4500
ChargePoint technology are market leaders in the manufacturing of sterile and high containment split butterfly valves for use pharmaceutical and bio-pharmaceutical ingredient processing.
ChargePoint Technology originally developed the patented split butterfly valve technology developed in conjunction with Glaxo Pharmaceuticals (now GlaxoSmithKline) in 1996. Known as a CTC, 'Contained Transfer Coupling', the fundamental features of the valve are still retained in the design as it can be seen today.
The patented split butterfly valve technology has become a pharmaceutical industry standard for the contained transfer of potent compounds from process to process.
ChargePoint’s product range includes:
The rise in #sterile manufacturing - A focus on #Containment : Article authored by Christian Dunne @ChargePointTech Read this article here: https://t.co/SvY7rhBDET (Pg: 54-55) pic.twitter.com/oNaxIulFI5— Pharma Magazine (@pharmafocusasia) February 9, 2018
Today is our final day and your last chance to come and visit us at #Lounges2018. Stop by stand F3.1 to come and say hi!— ChargePointTech (@ChargePointTech) February 8, 2018